Acadia Pharmaceuticals buy UBS Group AG

Summary

This prediction is currently active. The prediction for Acadia Pharmaceuticals disappoints with a performance of -20.76%. This prediction currently runs until 06.01.27. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this prediction

Performance without dividends (%)

Name	1w	1m
Acadia Pharmaceuticals	-3.916%	-3.916%
iShares Core DAX®	0.224%	1.487%
iShares Nasdaq 100	6.047%	16.188%
iShares Nikkei 225®	5.724%	11.690%
iShares S&P 500	2.172%	8.056%